![]() FEMSelect FEMSelect is a healthcare company focusing on the treatment of pelvic organ prolapse (POP) condition. | |||
Founding Date | Founding Date 2019 | Founding Date 2012 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations London, GB HQ | Locations HQ | Locations Groton, US HQ |
Employees | Employees 662% increase | Employees 157% increase | Employees 233% decrease |

FEMSelect is a healthcare company focusing on the treatment of pelvic organ prolapse (POP) condition.
View company
GestVision is a biotechnology company developing a test to help diagnose preeclampsia.
View company